Context:-
30% of USA small and medium biotechs are trading at less than cash in bank.
Effectively placing no value to their business or IP.
Also, USA biotech ETF is trading at less than half of peak in 2021.
IMU is not immune (pun intended) to world markets/events and "Trump effect" has had a created chaos in FDA. Big pharma has pulled or slowed R&D resulting in layoffs.
All this will pass. The primary concern for IMU is keeping the lights on - continuing trials, compelling data and raising enough cash to do so.
Cometh the hour.....
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
1.4¢ |
Change
0.001(7.69%) |
Mkt cap ! $104.5M | |||
| Open | High | Low | Value | Volume |
| 1.2¢ | 1.4¢ | 1.2¢ | $267.3K | 20.57M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 788815 | 1.3¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 1.4¢ | 13241534 | 29 |
View Market Depth
| Last trade - 16.10pm 20/06/2025 (20 minute delay) ? |
| IMU (ASX) Chart |